Sanabria Viviam, Romariz Simone, Braga Matheus, Foresti Maira Licia, Naffah-Mazzacoratti Maria da Graça, Mello Luiz Eugênio, Longo Beatriz M
Department of Physiology, Universidade Federal de São Paulo, São Paulo, Brazil.
Instituto D'Or de Pesquisa e Ensino, São Paulo, Brazil.
Front Neurosci. 2023 Feb 24;16:1100256. doi: 10.3389/fnins.2022.1100256. eCollection 2022.
Interest in the use of anticholinergics to prevent the development of epilepsy after traumatic brain injury (TBI) has grown since recent basic studies have shown their effectiveness in modifying the epileptogenic process. These studies demonstrated that treatment with anticholinergics, in the acute phase after brain injury, decreases seizure frequency, and severity, and the number of spontaneous recurrent seizures (SRS). Therefore, anticholinergics may reduce the risk of developing posttraumatic epilepsy (PTE). In this brief review, we summarize the role of the cholinergic system in epilepsy and the key findings from using anticholinergic drugs to prevent PTE in animal models and new clinical trial protocols. Furthermore, we discuss why treatment with anticholinergics is more likely to prevent PTE than treatment for other epilepsies.
自从最近的基础研究表明抗胆碱能药物在改变癫痫发生过程中具有有效性以来,人们对其用于预防创伤性脑损伤(TBI)后癫痫发展的兴趣与日俱增。这些研究表明,在脑损伤后的急性期使用抗胆碱能药物进行治疗,可降低癫痫发作频率、严重程度以及自发性反复癫痫发作(SRS)的次数。因此,抗胆碱能药物可能会降低创伤后癫痫(PTE)的发生风险。在这篇简短的综述中,我们总结了胆碱能系统在癫痫中的作用,以及在动物模型中使用抗胆碱能药物预防PTE的关键发现和新的临床试验方案。此外,我们还讨论了为什么使用抗胆碱能药物进行治疗比治疗其他癫痫更有可能预防PTE。